ECSP034528A - Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona - Google Patents

Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona

Info

Publication number
ECSP034528A
ECSP034528A EC2003004528A ECSP034528A ECSP034528A EC SP034528 A ECSP034528 A EC SP034528A EC 2003004528 A EC2003004528 A EC 2003004528A EC SP034528 A ECSP034528 A EC SP034528A EC SP034528 A ECSP034528 A EC SP034528A
Authority
EC
Ecuador
Prior art keywords
amino
methyl
tiazolidino
piridil
etoxi
Prior art date
Application number
EC2003004528A
Other languages
English (en)
Inventor
Andrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ECSP034528A publication Critical patent/ECSP034528A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe un compuesto, sal de sodio de 5-(4-(2-(N-metil-N-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona, o un solvato farmacéuticamente aceptable del mismo, que se caracteriza porque la sal de sodio es no hidroscópica o ligeramente higroscópica; se describen también una composición farmacéutica que contiene a dicho compuesto y el uso de dicho compuesto en medicina.
EC2003004528A 2000-09-29 2003-03-28 Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona ECSP034528A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0023971.5A GB0023971D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ECSP034528A true ECSP034528A (es) 2003-05-26

Family

ID=9900428

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004528A ECSP034528A (es) 2000-09-29 2003-03-28 Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona

Country Status (27)

Country Link
US (4) US20040014752A1 (es)
EP (2) EP1813612A1 (es)
JP (1) JP2004509959A (es)
KR (1) KR100917953B1 (es)
CN (4) CN100345846C (es)
AP (1) AP1738A (es)
AU (2) AU2001292028B2 (es)
BG (1) BG107679A (es)
BR (1) BR0114308A (es)
CA (1) CA2423975A1 (es)
CZ (1) CZ302181B6 (es)
DZ (1) DZ3480A1 (es)
EA (1) EA005109B1 (es)
EC (1) ECSP034528A (es)
GB (1) GB0023971D0 (es)
HU (1) HUP0301188A3 (es)
IL (2) IL155051A0 (es)
MA (1) MA25912A1 (es)
MX (1) MXPA03002868A (es)
NO (2) NO20031435L (es)
NZ (1) NZ524933A (es)
OA (1) OA12399A (es)
PL (1) PL363701A1 (es)
SK (1) SK3782003A3 (es)
UA (1) UA74842C2 (es)
WO (1) WO2002026735A1 (es)
ZA (1) ZA200302439B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133637B2 (en) * 2005-10-06 2012-03-13 Headwaters Technology Innovation, Llc Fuel cells and fuel cell catalysts incorporating a nanoring support
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
PL2512470T3 (pl) * 2009-12-15 2017-06-30 Octeta Therapeutics, Llc Oszczędzające ppar tiazolidynodiony i połączenia do leczenia chorób neurodegeneracyjnych

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1253236A (zh) * 1998-11-11 2000-05-17 李扬远 一种以重力差释放引力能的方法
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
IL188116A0 (en) 2008-03-20
ZA200302439B (en) 2004-04-28
CZ2003850A3 (cs) 2004-03-17
DZ3480A1 (fr) 2002-04-04
CA2423975A1 (en) 2002-04-04
HUP0301188A3 (en) 2005-04-28
AU2001292028B2 (en) 2005-04-21
IL155051A0 (en) 2003-10-31
EA005109B1 (ru) 2004-10-28
EP1332142A1 (en) 2003-08-06
US20040014752A1 (en) 2004-01-22
WO2002026735A1 (en) 2002-04-04
BR0114308A (pt) 2003-10-14
EA200300422A1 (ru) 2003-08-28
AP2003002767A0 (en) 2003-03-31
AP1738A (en) 2007-05-07
PL363701A1 (en) 2004-11-29
KR100917953B1 (ko) 2009-09-21
BG107679A (bg) 2003-12-31
AU9202801A (en) 2002-04-08
CN1915992A (zh) 2007-02-21
MA25912A1 (fr) 2003-10-01
US20040214866A1 (en) 2004-10-28
CN100345846C (zh) 2007-10-31
MXPA03002868A (es) 2004-12-06
CN101125853A (zh) 2008-02-20
JP2004509959A (ja) 2004-04-02
NZ524933A (en) 2004-12-24
US20050277679A9 (en) 2005-12-15
US20060004058A1 (en) 2006-01-05
UA74842C2 (en) 2006-02-15
NO20031435L (no) 2003-05-27
SK3782003A3 (en) 2004-06-08
CZ302181B6 (cs) 2010-12-01
EP1813612A1 (en) 2007-08-01
CN1915992B (zh) 2010-05-12
CN101125852A (zh) 2008-02-20
CN1466585A (zh) 2004-01-07
GB0023971D0 (en) 2000-11-15
US20070185167A1 (en) 2007-08-09
NO20076517L (no) 2003-04-29
HUP0301188A2 (hu) 2003-11-28
OA12399A (en) 2004-09-06
KR20030039377A (ko) 2003-05-17
NO20031435D0 (no) 2003-03-28

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
UY25304A1 (es) Forma hidratada de maleato de rosiglitazona
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
ECSP034528A (es) Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona
ECSP034505A (es) La sal de clorhidrato de 5-[4-(2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2, 4-diona
EA200300234A1 (ru) Тартратные соли производного тиазолидиндиона
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
EA200300231A1 (ru) Тартратные соли производного тиазолидиндиона
EA200300230A1 (ru) Тартратная соль производного тиазолидиндиона
CY1107421T1 (el) Τρυγικα αλατα παραγωγου θειαζολιδινοδιονης
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
DK1315724T3 (da) Thiazolidindionderivat og dets anvendelse som antidiabetikum
EA200300005A1 (ru) Соль тиазолидиндиона для лечения сахарного диабета
CY1106397T1 (el) Βενζολοσουλφονικη 5-(4-(2-(ν-μεθυλο-ν-(2-πυριδιλ)αμινο)αιθοξυ)βενζυλο) θειαζολιδινο-2,4-διονη ˙ διepγασια παρασκευης αυτης ˙ πολυμορφες ι,ιι και ιιι αυτης ˙ και χρηση αυτης ως φαρμακευτικο δραστικο συστατικο
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
ECSP003434A (es) Nuevos compuestos
ECSP003435A (es) Nuevos compuestos